Restenosis and its determinants in first and repeat coronary angioplasty

Insights

Repeat percutaneous transluminal coronary angioplasty (PTCA) offers better primary success and fewer complications than initial PTCA. However, restenosis remains a concern, with similar long-term outcomes for both procedures.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Restenosis is a primary limitation to the long-term success of percutaneous transluminal coronary angioplasty (PTCA).
  • Angiographic follow-up is crucial for evaluating PTCA outcomes, particularly restenosis rates.

Purpose of the Study:

  • To compare the primary and long-term results of initial PTCA (PTCA 1) versus repeat PTCA (PTCA 2) after restenosis.
  • To identify clinical, angiographic, and procedural factors influencing the outcomes of both primary and repeat PTCA.

Main Methods:

  • A comparative study involving 268 patients undergoing first PTCA and 66 patients undergoing repeat PTCA.
  • Assessment of 40 clinical, angiographic, and procedural factors.
  • High rates of angiographic follow-up (98% for PTCA 1, 92% for PTCA 2).

Main Results:

  • PTCA 2 demonstrated a higher primary success rate (91% vs. 67.5%) and fewer major complications (4.5% vs. 16%) compared to PTCA 1.
  • Higher inflation pressures and larger balloons were used in PTCA 2, leading to less residual stenosis.
  • Restenosis rates (27% vs. 36%) and time to recurrence were similar between PTCA 1 and PTCA 2.
  • Key predictors of restenosis included residual stenosis ≥45%, variant angina, and multivessel disease for PTCA 1; male sex and higher inflation pressure for PTCA 2.

Conclusions:

  • Repeat angioplasty is a viable option within PTCA therapy, offering improved initial outcomes.
  • Restenosis remains a significant challenge, necessitating strategies to minimize residual stenosis in primary PTCA.
  • Optimizing procedural techniques, such as potentially using lower inflation pressures to avoid dissection in repeat PTCA, may improve long-term results.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...